Neuropathic Pain

Abstract

Neuropathic pain management is challenging, and typically requires a multifaceted approach. There are several treatment options, both pharmacologic and nonpharmacologic. Of the available pharmacologic agents, those with the strongest supporting evidence include tricyclic antidepressants, serotonin–norepinephrine reuptake inhibitors, and certain antiseizure agents. There is emerging evidence for the use of cannabinoids, but conclusive studies are not available. Nonpharmacologic therapies that have been utilized in the management of neuropathic pain include acupuncture, massage therapy, and reflexology. Despite their use as adjunctive therapies in clinical practice, the current evidence supporting their use is not strong. For the management of neuropathic pain, combination therapies are generally employed. Additional studies for emerging therapies are still needed.

Keywords

tricyclics - cannabinoids - ketamine - acupuncture

• References

• 1 Attal N, Cruccu G, Baron R. , et al; European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17 (09) 1113-e88
• 2 Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev 2012; (07) CD008943
• 3 Raja SN, Haythornthwaite JA, Pappagallo M. , et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002; 59 (07) 1015-1021
• 4 Hollingshead J, Dühmke RM, Cornblath DR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2006; 3 (03) CD003726
• 5 Morley JS, Bridson J, Nash TP, Miles JB, White S, Makin MK. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliat Med 2003; 17 (07) 576-587
• 6 Norrbrink C, Lundeberg T. Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial. Clin J Pain 2009; 25 (03) 177-184
• 7 Chargaff E. A fever of reason the early way. Annu Rev Biochem 1975; 44: 1-18
• 8 Feinmann C. Pain relief by antidepressants: possible modes of action. Pain 1985; 23 (01) 1-8
• 9 Galer BS. Painful polyneuropathy: diagnosis, pathophysiology, and management. Semin Neurol 1994; 14 (03) 237-246
• 10 Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. ; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 63 (06) 959-965
• 11 Kieburtz K, Simpson D, Yiannoutsos C. , et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology 1998; 51 (06) 1682-1688
• 12 Shlay JC, Chaloner K, Max MB. , et al; Terry Beirn Community Programs for Clinical Research on AIDS. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. JAMA 1998; 280 (18) 1590-1595
• 13 Bril V, England J, Franklin GM. , et al; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76 (20) 1758-1765
• 14 Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindström T, Thorell LH. A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 1997; 13 (04) 313-323
• 15 Max MB. Endogenous monoamine analgesic systems: amitriptyline in painful diabetic neuropathy. Anesth Prog 1987; 34 (04) 123-127
• 16 Max MB, Culnane M, Schafer SC. , et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987; 37 (04) 589-596
• 17 Godfrey RG. A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Arch Intern Med 1996; 156 (10) 1047-1052
• 18 Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326 (19) 1250-1256
• 19 Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med 2000; 1 (04) 310-316
• 20 Sindrup SH, Gram LF, Brøsen K, Eshøj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990; 42 (02) 135-144
• 21 Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003; 60 (08) 1284-1289
• 22 Armstrong DG, Chappell AS, Le TK. , et al. Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes. Pain Med 2007; 8 (05) 410-418
• 23 Kaur H, Hota D, Bhansali A, Dutta P, Bansal D, Chakrabarti A. A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial. Diabetes Care 2011; 34 (04) 818-822
• 24 Wise TN, Fishbain DA, Holder-Perkins V. Painful physical symptoms in depression: a clinical challenge. Pain Med 2007; 8 (Suppl 2) S75-S82
• 25 Johannessen Landmark C. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs 2008; 22 (01) 27-47
• 26 Galer BS. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology 1995; 45 (12, Suppl 9): S17-S25 , discussion S35–S36
• 27 McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995; 311 (7012): 1047-1052
• 28 Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol 2006; 61 (03) 246-255
• 29 Moosa RS, McFadyen ML, Miller R, Rubin J. Carbamazepine and its metabolites in neuralgias: concentration-effect relations. Eur J Clin Pharmacol 1993; 45 (04) 297-301
• 30 Gomez-Arguelles JM, Dorado R, Sepulveda JM. , et al. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia. J Clin Neurosci 2008; 15 (05) 516-519
• 31 Dogra S, Beydoun S, Mazzola J, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 2005; 9 (05) 543-554
• 32 Grosskopf J, Mazzola J, Wan Y, Hopwood M. A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy. Acta Neurol Scand 2006; 114 (03) 177-180
• 33 Beydoun A, Shaibani A, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand 2006; 113 (06) 395-404
• 34 Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Mehta S, Botteman M. Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Pract 2014; 14 (02) 167-184
• 35 Gill D, Derry S, Wiffen PJ, Moore RA. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2011; (10) CD009183
• 36 Houtchens MK, Richert JR, Sami A, Rose JW. Open label gabapentin treatment for pain in multiple sclerosis. Mult Scler 1997; 3 (04) 250-253
• 37 Chapman V, Suzuki R, Chamarette HL, Rygh LJ, Dickenson AH. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 1998; 75 (2-3): 261-272
• 38 Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005; 6 (04) 253-260
• 39 Segal AZ, Rordorf G. Gabapentin as a novel treatment for postherpetic neuralgia. Neurology 1996; 46 (04) 1175-1176
• 40 Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280 (21) 1837-1842
• 41 Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009; 374 (9697): 1252-1261
• 42 Elwes RD, Binnie CD. Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine. Clin Pharmacokinet 1996; 30 (06) 403-415
• 43 Wiffen PJ, Derry S, Moore RA. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev 2011; (02) CD006044
• 44 Dworkin RH, Corbin AE, Young Jr JP. , et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003; 60 (08) 1274-1283
• 45 Sabatowski R, Gálvez R, Cherry DA. , et al; 1008-045 Study Group. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 2004; 109 (1-2): 26-35
• 46 Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004; 110 (03) 628-638
• 47 Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004; 63 (11) 2104-2110
• 48 Simpson DM, Schifitto G, Clifford DB. , et al; 1066 HIV Neuropathy Study Group. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology 2010; 74 (05) 413-420
• 49 Glazer S, Portenoy RK. Systemic local anesthetics in pain control. J Pain Symptom Manage 1991; 6 (01) 30-39
• 50 Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41 (07) 1024-1028
• 51 Tremont-Lukats IW, Challapalli V, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 2005; 101 (06) 1738-1749
• 52 Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985; 23 (04) 361-374
• 53 Chabal C, Jacobson L, Mariano A, Chaney E, Britell CW. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology 1992; 76 (04) 513-517
• 54 Challapalli V, Tremont-Lukats IW, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev 2005; (04) CD003345
• 55 Mahoney JM, Vardaxis V, Moore JL, Hall AM, Haffner KE, Peterson MC. Topical ketamine cream in the treatment of painful diabetic neuropathy: a randomized, placebo-controlled, double-blind initial study. J Am Podiatr Med Assoc 2012; 102 (03) 178-183
• 56 Barton DL, Wos EJ, Qin R. , et al. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer 2011; 19 (06) 833-841
• 57 Finch PM, Knudsen L, Drummond PD. Reduction of allodynia in patients with complex regional pain syndrome: a double-blind placebo-controlled trial of topical ketamine. Pain 2009; 146 (1-2): 18-25
• 58 Campbell-Fleming JM, Williams A. The use of ketamine as adjuvant therapy to control severe pain. Clin J Oncol Nurs 2008; 12 (01) 102-107
• 59 Ware MA, Wang T, Shapiro S. , et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 2010; 182 (14) E694-E701
• 60 Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain 2013; 14 (02) 136-148
• 61 Wallace MS, Marcotte TD, Umlauf A, Gouaux B, Atkinson JH. Efficacy of inhaled cannabis on painful diabetic neuropathy. J Pain 2015; 16 (07) 616-627
• 62 Abrams DI, Jay CA, Shade SB. , et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 2007; 68 (07) 515-521
• 63 Ellis RJ, Toperoff W, Vaida F. , et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 2009; 34 (03) 672-680
• 64 Ware MA, Wang T, Shapiro S, Collet JP. ; COMPASS study team. Cannabis for the management of pain: assessment of safety study (COMPASS). J Pain 2015; 16 (12) 1233-1242
• 65 Public Policy Statement on Medical Marijuana. American Society of Addiction Medicine. April 2010 . Available at: http://www.asam.org/advocacy/find-a-policy-statement/view-policy-statement/public-policy-statements/2011/12/15/medical-marijuana . Accessed May 11, 2013
• 66 ASAM Writing Committee to Develop a Response to State-Level Proposals to Legalize Marijuana. State-Level Proposals to Legalize Marijuana. American Society of Addiction Medicine. July 25, 2012 . Available at: http://www.asam.org/advocacy/find-a-policy-statement/view-policy-statement/public-policy-statements/2012/07/30/state-level-proposals-to-legalize-marijuana . Accessed May 11, 2013
• 67 The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991; 151 (11) 2225-2229
• 68 Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004; 328 (7446): 991
• 69 McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000; 49 (06) 574-579
• 70 Irving G, Backonja M, Rauck R, Webster LR, Tobias JK, Vanhove GF. NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia. Clin J Pain 2012; 28 (02) 101-107
• 71 Derry S, Lloyd R, Moore RA, McQuay HJ. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2009; (04) CD007393
• 72 Simpson DM, Brown S, Tobias J. ; NGX-4010 C107 Study Group. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008; 70 (24) 2305-2313
• 73 Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology 2005; 103 (01) 140-146
• 74 Nalamachu S, Crockett RS, Gammaitoni AR, Gould EM. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study. MedGenMed 2006; 8 (03) 33
• 75 Affaitati G, Fabrizio A, Savini A. , et al. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther 2009; 31 (04) 705-720
• 76 Campbell CM, Kipnes MS, Stouch BC. , et al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain 2012; 153 (09) 1815-1823
• 77 Byas-Smith MG, Max MB, Muir J, Kingman A. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage ‘enriched enrollment’ design. Pain 1995; 60 (03) 267-274
• 78 Stow PJ, Glynn CJ, Minor B. EMLA cream in the treatment of post-herpetic neuralgia. Efficacy and pharmacokinetic profile. Pain 1989; 39 (03) 301-305
• 79 Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008; 64 (03) 274-283
• 80 Yuan RY, Sheu JJ, Yu JM. , et al. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology 2009; 72 (17) 1473-1478
• 81 Ghasemi M, Ansari M, Basiri K, Shaigannejad V. The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy. J Res Med Sci 2014; 19 (02) 106-111
• 82 Jeynes LC, Gauci CA. Evidence for the use of botulinum toxin in the chronic pain setting--a review of the literature. Pain Pract 2008; 8 (04) 269-276
• 83 Aoki KR. Future aspects of botulinum neurotoxins. J Neural Transm (Vienna) 2008; 115 (04) 567-573
• 84 Oh HM, Chung ME. Botulinum toxin for neuropathic pain: a review of the literature. Toxins (Basel) 2015; 7 (08) 3127-3154
• 85 Chen W, Yang GY, Liu B, Manheimer E, Liu J-P. Manual acupuncture for treatment of diabetic peripheral neuropathy: a systematic review of randomized controlled trials. PLoS One 2013; 8 (09) e73764
• 86 Dimitrova A, Murchison C, Oken B. Acupuncture for the treatment of peripheral neuropathy: a systematic review and meta-analysis. J Altern Complement Med 2017; 23 (03) 164-179
• 87 Kong J, Kaptchuk TJ, Polich G. , et al. An fMRI study on the interaction and dissociation between expectation of pain relief and acupuncture treatment. Neuroimage 2009; 47 (03) 1066-1076
• 88 Park R, Park C. Comparison of foot bathing and foot massage in chemotherapy-induced peripheral neuropathy. Cancer Nurs 2015; 38 (03) 239-247
• 89 Gok Metin Z, Arikan Donmez A, Izgu N, Ozdemir L, Arslan IE. Aromatherapy massage for neuropathic pain and quality of life in diabetic patients. J Nurs Scholarsh 2017; 49 (04) 379-388
• 90 Kurt S, Can G. Reflexology in the management of chemotherapy induced peripheral neuropathy: a pilot randomized controlled trial. Eur J Oncol Nurs 2018; 32: 12-19
• 91 Dalal K, Maran VB, Pandey RM, Tripathi M. Determination of efficacy of reflexology in managing patients with diabetic neuropathy: a randomized controlled clinical trial. Evid Based Complement Alternat Med 2014; 2014: 843036
• 92 Cruccu G, Garcia-Larrea L, Hansson P. , et al. EAN guidelines on central neurostimulation therapy in chronic pain conditions. Eur J Neurol 2016; 23 (10) 1489-1499
• 93 Khedr EM, Kotb H, Kamel NF, Ahmed MA, Sadek R, Rothwell JC. Long lasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 2005; 76 (06) 833-838
• 94 André-Obadia N, Mertens P, Gueguen A, Peyron R, Garcia-Larrea L. Pain relief by rTMS: differential effect of current flow but no specific action on pain subtypes. Neurology 2008; 71 (11) 833-840
• 95 André-Obadia N, Peyron R, Mertens P, Mauguière F, Laurent B, Garcia-Larrea L. Transcranial magnetic stimulation for pain control. Double-blind study of different frequencies against placebo, and correlation with motor cortex stimulation efficacy. Clin Neurophysiol 2006; 117 (07) 1536-1544
• 96 Yılmaz B, Kesikburun S, Yaşar E, Tan AK. The effect of repetitive transcranial magnetic stimulation on refractory neuropathic pain in spinal cord injury. J Spinal Cord Med 2014; 37 (04) 397-400
• 97 Weintraub MI, Wolfe GI, Barohn RA. , et al; Magnetic Research Group. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehabil 2003; 84 (05) 736-746
• 98 Najafi B, Crews RT, Wrobel JS. A novel plantar stimulation technology for improving protective sensation and postural control in patients with diabetic peripheral neuropathy: a double-blinded, randomized study. Gerontology 2013; 59 (05) 473-480
• 99 Clifft JK, Kasser RJ, Newton TS, Bush AJ. The effect of monochromatic infrared energy on sensation in patients with diabetic peripheral neuropathy: a double-blind, placebo-controlled study. Diabetes Care 2005; 28 (12) 2896-2900
• 100 Lavery LA, Murdoch DP, Williams J, Lavery DC. Does anodyne light therapy improve peripheral neuropathy in diabetes? A double-blind, sham-controlled, randomized trial to evaluate monochromatic infrared photoenergy. Diabetes Care 2008; 31 (02) 316-321
• 101 Nawfar SA, Yacob NB. Effects of monochromatic infrared energy therapy on diabetic feet with peripheral sensory neuropathy: a randomised controlled trial. Singapore Med J 2011; 52 (09) 669-672
• 102 Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment. Mayo Clin Proc 2015; 90 (04) 532-545
• 103 Brooks KG, Kessler TL. Treatments for neuropathic pain. Clin Pharm 2017; 9 (12)